Use of non-steroidal anti-inflammatory agents in combination with compounds that have FP prostaglandin agonist activity to treat glaucoma and ocular hypertension
US6342524B1 · kind B1 · utility
14Cited by
50References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 22, 2000 |
| Grant date | Jan 29, 2002 |
| Priority date | — |
| Expiry date | May 22, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods and compositions for the treatment of glaucoma and ocular hypertension, comprising the administration of a prostaglandin analog and a prostaglandin synthesis inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.